You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Dow
Johnson and Johnson
Boehringer Ingelheim
Harvard Business School

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Details for Patent: 6,780,877

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,780,877
Title: Acid addition salt of optically active piperidine compound and process for preparing the same
Abstract:The present invention is to provide a benzenesulfonic acid salt and a benzoic acid salt of (S)-4-[4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]butanoic acid represented by the formula (I): ##STR1## wherein * represents an asymmetric carbon, which are excellent in antihistaminic activity and anti-allergic activity, and a process for producing the same.
Inventor(s): Kita; Jun-ichiro (Ube, JP), Fujiwara; Hiroshi (Ube, JP), Takamura; Shinji (Ube, JP)
Assignee: Ube Industries, Ltd. (Ube, JP) Tanabe Seiyaku Co., Ltd. (Osaka, JP)
Application Number:09/949,809
Patent Claim Types:
see list of patent claims
Compound; Process; Composition;

Drugs Protected by US Patent 6,780,877

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,780,877

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan8-347851Dec 26, 1996
Japan8-347853Dec 26, 1996
Japan8-347895Dec 26, 1996

International Family Members for US Patent 6,780,877

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 217872   Start Trial
Australia 7890698   Start Trial
Canada 2275987   Start Trial
China 1098262   Start Trial
China 1231478   Start Trial
China 1242013   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
AstraZeneca
McKinsey
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.